EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Resistance gene–guided genome mining reveals the roseopurpurins as inhibitors of cyclin-dependent kinases

Kyle L Dunbar, Bruno Perlatti, Nicholas Liu iD, Amber Cornelius, Daniel Mummau iD, Yi-Ming Chiang iD, Lawrence Hon, Monika Nimavat iD, Jason Pallas iD, Sina Kordes, Ho Leung Ng, Colin J B Harvey iD

Proceedings of the National Academy of Sciences · 2023

DOI: 10.1073/pnas.2310522120 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2023. Verfasst von Kyle L Dunbar und 11 weiteren Autor:innen. Beteiligte Einrichtung: Hexagon Bio, Menlo Park, CA 94025. Hauptthemen laut MEDLINE: Cyclin-Dependent Kinases, Neoplasms. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

With the significant increase in the availability of microbial genome sequences in recent years, resistance gene–guided genome mining has emerged as a powerful approach for identifying natural products with specific bioactivities. Here, we present the use of this approach to reveal the roseopurpurins as potent inhibitors of cyclin-dependent kinases (CDKs), a class of cell cycle regulators implicated in multiple cancers. We identified a biosynthetic gene cluster (BGC) with a putative resistance gene with homology to human CDK2. Using targeted gene disruption and transcription factor overexpression in Aspergillus uvarum , and heterologous expression of the BGC in Aspergillus nidulans, we demonstrated that roseopurpurin C ( 1 ) is produced by this cluster and characterized its biosynthesis. We determined the potency, specificity, and mechanism of action of 1 as well as multiple intermediates and shunt products produced from the BGC. We show that 1 inhibits human CDK2 with a K iapp of 44 nM, demonstrates selectivity for clinically relevant members of the CDK family, and induces G1 cell cycle arrest in HCT116 cells. Structural analysis of 1 complexed with CDK2 revealed the molecular basis of ATP-competitive inhibition.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cyclin-Dependent KinasesNeoplasmsHumansCyclin-Dependent Kinase 2CyclinsCell CycleEnzyme Inhibitors

Stichwörter der Autor:innen

biosynthesisgenome miningnatural products

Substanzen

Cyclin-Dependent KinasesCyclin-Dependent Kinase 2CyclinsEnzyme Inhibitors

Autor:innen und Institutionen

  • Hexagon Bio, Menlo Park, CA 94025.
  • Proteros Biostructures GmbH, Planegg D-82152, Germany.

ORCID-Profile: Nicholas Liu, Daniel Mummau, Yi-Ming Chiang, Monika Nimavat, Jason Pallas, Colin J B Harvey

Zitieren

APA

Dunbar, K. L., Perlatti, B., Liu, N., Cornelius, A., Mummau, D., Chiang, Y. M., Hon, L., Nimavat, M., Pallas, J., Kordes, S., Ng, H. L., & Harvey, C. J. B. (2023). Resistance gene–guided genome mining reveals the roseopurpurins as inhibitors of cyclin-dependent kinases. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2310522120

Vancouver

Dunbar KL, Perlatti B, Liu N, Cornelius A, Mummau D, Chiang YM, et al. Resistance gene–guided genome mining reveals the roseopurpurins as inhibitors of cyclin-dependent kinases. Proceedings of the National Academy of Sciences. 2023. doi:10.1073/pnas.2310522120

BibTeX
@article{Dunbar2023,
  author = {Dunbar, Kyle L and Perlatti, Bruno and Liu, Nicholas and Cornelius, Amber and Mummau, Daniel and Chiang, Yi-Ming and Hon, Lawrence and Nimavat, Monika and Pallas, Jason and Kordes, Sina and Ng, Ho Leung and Harvey, Colin J B},
  title = {Resistance gene–guided genome mining reveals the roseopurpurins as inhibitors of cyclin-dependent kinases},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2023},
  doi = {10.1073/pnas.2310522120}
}
Kostenlos starten →